India’s Cipla To Acquire Two US Generics Businesses For $550 Million
India’s fourth-biggest generics maker Cipla Ltd. has agreed to buy two U.S.-based generics companies for a total of $550 million. The acquisition is expected to help the company expand in the world’s largest pharmaceuticals market.